Scilex's Semnur Pharmaceuticals to go public through $2.5B SPAC merger as it advances sciatica prospect
3rd September 2024 Uncategorised 0Scilex’s Semnur Pharmaceuticals to go public through $2.5B SPAC merger as it advances sciatica prospect zbecker Tue, 09/03/2024 – 15:50 More: Scilex's Semnur Pharmaceuticals to go public through .5B SPAC merger as it advances sciatica prospect Source: fierce
read more